![Thomas Wei](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Thomas Wei
Chief Tech/Sci/R&D Officer at
AURINIA PHARMACEUTICALS INC.
Profile
Thomas Wei is currently Managing Director at Tang Capital Management LLC since 2015 and Chief Scientific Officer at Aurinia Pharmaceuticals, Inc. starting in 2026.
Former roles include Managing Director at Piper Sandler & Co. (Broker), Managing Director at Jefferies LLC from 2009 to 2014, Managing Director & Principal at U.S.
Bancorp Piper Jaffray Ventures in 2009, Research Associate at Deutsche Bank Securities, Inc. from 2000 to 2003, Analyst at Adams Harkness & Hill Investment Banking from 1999 to 2000, and Chief Scientific Officer at Odonate, Inc. from 2018 to 2021.
Education includes an undergraduate degree from Harvard University in 1997 and an MBA from the University of Oxford in 1998.
Thomas Wei active positions
| Companies | Position | Start |
|---|---|---|
| AURINIA PHARMACEUTICALS INC. | Chief Tech/Sci/R&D Officer | 21/03/2026 |
Tang Capital Management LLC
 Tang Capital Management LLC Investment ManagersFinance Tang Capital focuses on investments in small-cap US companies in the life sciences sector. | Portfolio Manager-Equities | 01/01/2015 |
Former positions of Thomas Wei
| Companies | Position | End |
|---|---|---|
| ODONATE, INC. | Chief Tech/Sci/R&D Officer | 01/12/2021 |
U.S. Bancorp Piper Jaffray Ventures
 U.S. Bancorp Piper Jaffray Ventures Investment ManagersFinance Piper Jaffray Ventures focuses on emerging-growth companies in medical devices, healthcare services and technology. | Corporate Officer/Principal | 30/09/2009 |
Piper Sandler & Co. (Broker)
 Piper Sandler & Co. (Broker) Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 15/08/2009 |
Deutsche Bank Securities, Inc.
 Deutsche Bank Securities, Inc. Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | - |
Adams Harkness & Hill Investment Banking
 Adams Harkness & Hill Investment Banking Investment ManagersFinance Part of Canaccord Genuity Group, Inc., Adams Harkness & Hill Investment Banking is a company based in Boston, MA. | Corporate Officer/Principal | 30/04/2000 |
Training of Thomas Wei
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
89
1st degree connections
10
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 10 |
|---|---|
Deutsche Bank Securities, Inc.
Deutsche Bank Securities, Inc. Investment Banks/BrokersFinance Provides brokerage services | Finance |
Piper Sandler & Co. (Broker)
Piper Sandler & Co. (Broker) Investment Banks/BrokersFinance Provides brokerage services | Finance |
Tang Capital Management LLC
Tang Capital Management LLC Investment ManagersFinance Tang Capital focuses on investments in small-cap US companies in the life sciences sector. | Finance |
Jefferies LLC
 Jefferies LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Oxford
 University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Adams Harkness & Hill Investment Banking
Adams Harkness & Hill Investment Banking Investment ManagersFinance Part of Canaccord Genuity Group, Inc., Adams Harkness & Hill Investment Banking is a company based in Boston, MA. | Finance |
U.S. Bancorp Piper Jaffray Ventures
U.S. Bancorp Piper Jaffray Ventures Investment ManagersFinance Piper Jaffray Ventures focuses on emerging-growth companies in medical devices, healthcare services and technology. | Finance |
Aurinia Pharmaceuticals, Inc.
 Aurinia Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company, which focuses on discovery and development of immunomodulating therapeutics | Health Technology |
Odonate, Inc.
 Odonate, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for cancer treatment | Health Technology |
- Stock Market
- Insiders
- Thomas Wei
